Nathalie Barrett
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Sirtuins and Resveratrol in Medicine, Tea Polyphenols and Effects, Protein Degradation and Inhibitors, African Studies and Geopolitics
Most-Cited Works
- → KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe(2019)93 cited
- → Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors(2015)79 cited
- → Clones from the human gene complex coding for salivary proline-rich proteins.(1984)65 cited
- → Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses(2012)30 cited
- → Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes(2024)14 cited
- → Correction: Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses(2012)3 cited
- Modave/Modave : fouilles dans la grotte du Trou Al'Wesse en 2021(2020)
- Modave/Modave. Trou Al’Wesse, fouilles 2018(2019)
- → Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library(2025)